Source: Ohio Board of Pharmacy
The Ohio Board of Pharmacy (OBP) has released the 2024-25 Ohio Automated Rx Reporting System (OARRS) Report. This report continues to show encouraging trends that are the result of Ohio’s efforts to promote the safe and responsible prescribing of controlled substance medications.
OARRS is an indispensable healthcare tool to address prescription drug abuse and misuse. Use of the system continues to increase at record rates thanks to the OBP’s efforts to promote the integration of OARRS into electronic health records and pharmacy dispensing systems. Since implementing the first statewide integration program in the nation, the OBP has onboarded a significant number of health systems, clinics, and pharmacies throughout the state. Due to these efforts, more than 95% of Ohio prescribers access OARRS via an integrated workflow.
- The number of opioid doses and prescriptions dispensed to Ohio patients continued to decrease. Total doses of opioids decreased from a high of 793 million in 2012 to 276 million in 2025, a 65.2% decrease. The total number of opioid prescriptions decreased by 7.4 million between 2012 and 2025, a 58.7% decrease.
- The number of benzodiazepine doses and prescriptions dispensed to Ohio patients continued to decrease. Total doses of benzodiazepines decreased from a high of 297 million in 2012 to 139 million in 2025, a 53.2% decrease. The total number of benzodiazepine prescriptions decreased by 2.1 million between 2012 and 2025, a 42.9% decrease.
- In 2024, OARRS incorporated an alert to notify clinicians of non-fatal overdose events treated at Ohio emergency departments. This data provides critical information to prescribers and pharmacists when deciding on the appropriate prescribing and/or dispensing of medications. For more information, visit the OBP website.
- In 2025, OARRS was updated so Patient Reports include information on patients who may be experiencing MOUD treatment discontinuation and patients who may meet criteria in the Ohio Administrative Code that require a physician or other healthcare professional to offer a prescription for an overdose reversal medication, such as naloxone. For more information, view the OARRS guidance documents for MOUD Clarity and CO-Rx Clarity.
View the full report on the OBP website.